Published in Crit Care Med on August 01, 1990
Sepsis Associated Encephalopathy (SAE) Biomarkers | NCT03133208
Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA (2010) 10.82
Human malarial disease: a consequence of inflammatory cytokine release. Malar J (2006) 2.36
Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Crit Care Med (2008) 1.97
Pathogenesis of malaria and clinically similar conditions. Clin Microbiol Rev (2004) 1.87
Endotoxemia: methods of detection and clinical correlates. Clin Microbiol Rev (1995) 1.73
Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med (2007) 1.69
Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J Neuroinflammation (2008) 1.46
Cerebral perfusion in sepsis-associated delirium. Crit Care (2008) 1.33
The impact of body temperature abnormalities on the disease severity and outcome in patients with severe sepsis: an analysis from a multicenter, prospective survey of severe sepsis. Crit Care (2013) 1.32
Sepsis-associated encephalopathy. Nat Rev Neurol (2012) 1.30
Bench-to-bedside review: thrombocytopenia-associated multiple organ failure--a newly appreciated syndrome in the critically ill. Crit Care (2006) 1.15
Cell wall-mediated neuronal damage in early sepsis. Infect Immun (2006) 1.14
Science review: The brain in sepsis--culprit and victim. Crit Care (2004) 1.11
Infection-induced inflammation and cerebral injury in preterm infants. Lancet Infect Dis (2014) 1.10
Sepsis-associated encephalopathy: not just delirium. Clinics (Sao Paulo) (2011) 1.07
Understanding brain dysfunction in sepsis. Ann Intensive Care (2013) 1.06
Effect of magnesium sulfate administration on blood-brain barrier in a rat model of intraperitoneal sepsis: a randomized controlled experimental study. Crit Care (2004) 1.04
Adiponectin-deficiency exaggerates sepsis-induced microvascular dysfunction in the mouse brain. Obesity (Silver Spring) (2011) 1.03
Neuro-oxidative-nitrosative stress in sepsis. J Cereb Blood Flow Metab (2011) 1.01
Hypothermia predicts mortality in critically ill elderly patients with sepsis. BMC Geriatr (2010) 0.98
Cerebral net exchange of large neutral amino acids after lipopolysaccharide infusion in healthy humans. Crit Care (2010) 0.94
Memory-enhancing treatments reverse the impairment of inhibitory avoidance retention in sepsis-surviving rats. Crit Care (2008) 0.93
The incidence, causes, and prognostic significance of new-onset thrombocytopenia in intensive care units: a prospective cohort study in a Korean hospital. J Korean Med Sci (2012) 0.90
Curcumin modulates leukocyte and platelet adhesion in murine sepsis. Microcirculation (2010) 0.89
Cerebral perfusion in sepsis. Crit Care (2010) 0.87
Sepsis-associated encephalopathy: a magnetic resonance imaging and spectroscopy study. J Cereb Blood Flow Metab (2009) 0.87
Personalizing blood pressure management in septic shock. Ann Intensive Care (2015) 0.86
Human severe sepsis cytokine mixture increases β2-integrin-dependent polymorphonuclear leukocyte adhesion to cerebral microvascular endothelial cells in vitro. Crit Care (2015) 0.85
Pattern of brain injury in the acute setting of human septic shock. Crit Care (2013) 0.85
Endotoxin-induced monocytic microparticles have contrasting effects on endothelial inflammatory responses. PLoS One (2014) 0.84
Presepsis depressive symptoms are associated with incident cognitive impairment in survivors of severe sepsis: a prospective cohort study of older Americans. J Am Geriatr Soc (2012) 0.83
Thrombocytopenia in critically ill surgical patients: a case-control study evaluating attributable mortality and transfusion requirements. Crit Care (1999) 0.83
Clinical neurophysiological assessment of sepsis-associated brain dysfunction: a systematic review. Crit Care (2014) 0.81
Heme oxygenase-1 induction in the brain during lipopolysaccharide-induced acute inflammation. Neuropsychiatr Dis Treat (2008) 0.81
Body temperature abnormalities in non-neurological critically ill patients: a review of the literature. J Intensive Care (2014) 0.80
The peroxynitrite catalyst WW-85 improves microcirculation in ovine smoke inhalation injury and septic shock. Burns (2011) 0.80
Sepsis Associated Encephalopathy. Adv Med (2014) 0.80
CD40-CD40 Ligand Pathway is a Major Component of Acute Neuroinflammation and Contributes to Long-term Cognitive Dysfunction after Sepsis. Mol Med (2015) 0.79
Multiple organ dysfunction syndrome in humans and animals. J Vet Intern Med (2014) 0.78
Prevalence of occult adrenal insufficiency and the prognostic value of a short corticotropin stimulation test in patients with septic shock. Indian J Crit Care Med (2009) 0.78
Elevated serum vascular cell adhesion molecule-1 is associated with septic encephalopathy in adult community-onset severe sepsis patients. Biomed Res Int (2014) 0.78
Brain Oxidative Stress During Experimental Sepsis Is Attenuated by Simvastatin Administration. Mol Neurobiol (2016) 0.77
Imaging in sepsis-associated encephalopathy--insights and opportunities. Nat Rev Neurol (2013) 0.76
Brain dysfunction in sepsis: what can we learn from cerebral perfusion studies? Crit Care (2008) 0.75
Baseline acetylcholinesterase activity and serotonin plasma levels are not associated with delirium in critically ill patients. Rev Bras Ter Intensiva (2015) 0.75
Sepsis associated delirium mimicking postoperative delirium as the initial presenting symptom of urosepsis in a patient who underwent nephrolithotomy. World J Clin Cases (2016) 0.75
Coma during Salmonella typhimurium septicaemia. Postgrad Med J (1997) 0.75
Histological Architecture Underlying Brain-Immune Cell-Cell Interactions and the Cerebral Response to Systemic Inflammation. Front Immunol (2017) 0.75
Severe sepsis: Low expression of the renin-angiotensin system is associated with poor prognosis. Exp Ther Med (2014) 0.75
Peripheral T-lymphocyte and natural killer cell population imbalance is associated with septic encephalopathy in patients with severe sepsis. Exp Ther Med (2016) 0.75
Intensive care. Postgrad Med J (1993) 0.75
Gram-negative sepsis: what dilemma? Clin Microbiol Rev (1993) 0.75
Outcome of severe infections in afebrile neutropenic cancer patients. Radiol Oncol (2016) 0.75
Dioscin relieves endotoxemia induced acute neuro-inflammation and protect neurogenesis via improving 5-HT metabolism. Sci Rep (2017) 0.75
Acute Kidney Injury as a Risk Factor for Delirium and Coma during Critical Illness. Am J Respir Crit Care Med (2016) 0.75
Sepsis-Associated Encephalopathy: The Blood-Brain Barrier and the Sphingolipid Rheostat. Front Immunol (2017) 0.75
Aversive memory in sepsis survivor rats. J Neural Transm (Vienna) (2010) 0.75
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med (1996) 5.25
Cellular immunity in vitro. I. Immunologically mediated enhancement of macrophage bactericidal capacity. J Exp Med (1971) 4.94
Importance of functional measures in predicting mortality among older hospitalized patients. JAMA (1998) 4.33
Enhancement of macrophage bactericidal capacity by antigenically stimulated immune lymphocytes. Cell Immunol (1972) 3.56
Impaired delayed hypersensitivity in patients with lepromatous leprosy. Lancet (1966) 3.26
A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. JAMA (1991) 3.25
Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Society of Critical Care Medicine. Crit Care Med (1995) 3.19
Staphylococcus aureus. The persistent pathogen (first of two parts). N Engl J Med (1984) 3.15
Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. JAMA (1997) 3.11
Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab (1994) 2.84
Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Crit Care Med (1993) 2.84
Serious infections from Bacillus sp. JAMA (1979) 2.67
A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crit Care Med (1995) 2.48
Staphylococcus aureus. The persistent pathogen (second of two parts). N Engl J Med (1984) 2.23
In vitro activity of rifampin alone and in combination with nafcillin and Vancomycin against pathogenic strains of Staphylococcus aureus. Antimicrob Agents Chemother (1978) 2.21
Teichoic acid serologic diagnosis of staphylococcal endocarditis. Use of gel diffusion and counterimmunoelectrophoretic methods. Ann Intern Med (1975) 2.15
Microbiologic study of street heroin and injection paraphernalia. J Infect Dis (1974) 2.10
The present medical database needs reorganization. It's time for a change! Arch Intern Med (1990) 2.02
Acute rupture of the diaphragm in blunt trauma: analysis of 60 patients. J Trauma (1986) 2.01
Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest (1993) 2.00
Malaria: host-defense mechanisms and complications. Ann Intern Med (1970) 2.00
Epidemiology and clinical significance of blood cultures positive for coagulase-negative staphylococcus. Infect Control (1985) 1.95
Surgical implications of jejunal diverticula. South Med J (1988) 1.90
Interactions of C-reactive protein with the complement system. II. C-reactive protein-mediated consumption of complement by poly-L-lysine polymers and other polycations. J Exp Med (1975) 1.88
Staphylococcus aureus bacteremia: relationship between formation of antibodies to teichoic acid and development of metastatic abscesses. J Infect Dis (1978) 1.88
Staphylococcal endocarditis in drug users. Clinical and microbiologic aspects. Arch Intern Med (1975) 1.83
Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome. Clin Infect Dis (2001) 1.70
Risk of right bundle-branch block and complete heart block during pulmonary artery catheterization. Crit Care Med (1989) 1.62
Surgical significance of acquired ileal diverticulosis. Am Surg (1990) 1.58
Teichoic acid antibodies in the diagnosis of serious infections with Staphylococcus aureus. Ann Intern Med (1976) 1.49
Antagonism of toxigenic Clostridium difficile by nontoxigenic C. difficile. J Infect Dis (1983) 1.45
Population dynamics of ingested Clostridium difficile in the gastrointestinal tract of the Syrian hamster. J Infect Dis (1985) 1.44
Fulminant hepatic failure from a sea anemone sting. Ann Intern Med (1994) 1.43
Alternate-day prednisone therapy. Evaluation of delayed hypersensitivity responses, control of disease and steroid side effects. N Engl J Med (1969) 1.42
Prior healthcare utilization as a predictor of survival for medical intensive care unit patients. Crit Care Med (2000) 1.42
Septicemia due to Mycoplasma hominis type 1. N Engl J Med (1965) 1.40
Immunologic reactivity in patients with leprosy. Ann Intern Med (1969) 1.39
Surgical scar endometrioma. Surg Gynecol Obstet (1993) 1.36
Treatment of death in the analysis of longitudinal studies of gerontological outcomes. J Gerontol A Biol Sci Med Sci (2010) 1.35
Gnotobiotic models for study of the microbial ecology of Clostridium difficile and Escherichia coli. J Infect Dis (1986) 1.34
Effects of acetylsalicylic acid on the canine response to endotoxin. J Pharmacol Exp Ther (1967) 1.33
Detection of endotoxin in cerebrospinal and joint fluids by limulus assay. Arch Intern Med (1977) 1.33
Endotoxin-induced modification of Plasmodium berghei infection in mice. J Immunol (1969) 1.31
Reticuloendothelial system phagocytic function in patients with Hodgkin's disease. J Clin Invest (1967) 1.30
Rapid identification of Staphylococcus aureus by using lysostaphin sensitivity. J Clin Microbiol (1980) 1.30
Perforated jejunal diverticula. Am Surg (1996) 1.29
Impaired concanavalin A-inducible suppressor T-cell activity in active alcoholic liver disease. Gastroenterology (1981) 1.28
Septic sequelae after splenectomy for trauma in adults. Am J Surg (1983) 1.27
ICU survival of patients with the acquired immunodeficiency syndrome. Crit Care Med (1986) 1.24
Migration inhibitory factor and macrophage bactericidal function. Infect Immun (1972) 1.24
Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J Infect Dis (1974) 1.24
Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group. J Infect Dis (1996) 1.21
Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Clin Pharmacol Ther (1999) 1.21
Reticuloendothelial blockade produced by antilymphocyte serum. Lancet (1969) 1.20
Cardiorespiratory and metabolic responses to liver E. coli and endotoxin in the monkey. J Appl Physiol (1969) 1.16
Spontaneous perforation of a pancreatic pseudocyst into the colon and duodenum. Am J Surg (1973) 1.16
Neutropenia probably resulting from nafcillin. JAMA (1975) 1.15
Prospective, randomized trial of the biofragmentable anastomosis ring. The BAR Investigational Group. Am J Surg (1991) 1.14
Effects of endotoxin on pulmonary capillary permeability, ultrastructure, and surfactant. Surg Gynecol Obstet (1969) 1.14
Surgical treatment of pancreatic pseudocysts. Analysis of 119 cases. Ann Surg (1979) 1.13
Protective Effect of Antilymphocyte Serum on Mice Infected with Plasmodium berghei. Science (1969) 1.13
Maximum surgical blood order schedule reduces hospital costs. Am Surg (1987) 1.12
Mesenteric vascular responses to endotoxin in the monkey and dog. Am J Physiol (1970) 1.12
The pulmonary ultrastructure in septic shock. Exp Mol Pathol (1970) 1.12
Evaluation of B.663 in human leprosy. Int J Lepr Other Mycobact Dis (1967) 1.11
Upper-airway obstruction as a complication of oral anticoagulation therapy. Crit Care Med (1986) 1.10
Staphylococcal septicemia and disseminated intravascular coagulation. Staphylococcus aureus endocarditis mimicking meningococcemia. Arch Intern Med (1977) 1.09
Antibody levels to bacterial peptidoglycan in human sera during the time course of endocarditis and bacteremic infections caused by Staphylococcus aureus. Infect Immun (1981) 1.09
Effect of indomethacin in endotoxin shock in the dog. Proc Soc Exp Biol Med (1967) 1.09
A model for thrombin protection against endotoxin. Thromb Res (1984) 1.09
Effectiveness of steroid/antibiotic treatment in primates administered LD100 Escherichia coli. Ann Surg (1981) 1.08
Adverse reactions to methicillin and nafcillin during treatment of serious Staphylococcus aureaus infections. Arch Intern Med (1978) 1.08
Management of arterial injuries in blunt trauma of the extremity. Surg Gynecol Obstet (1981) 1.08
Recognition of intra-abdominal injury in blunt trauma victims. A prospective study comparing physical examination with peritoneal lavage. Am Surg (1982) 1.07
Survival of primates in LD100 septic shock following steroid/antibiotic therapy. J Surg Res (1980) 1.07
Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med (1993) 1.05
Detection of the 'hyperdynamic state' of sepsis in the baboon during lethal E. coli infusion. J Trauma (1983) 1.04
Response of the subhuman primate in gram-negative septicemia induced by live Escherichia coli. Surg Gynecol Obstet (1971) 1.04
Comparison of canine responses to Escherichia coli organisms and endotoxin. Surg Gynecol Obstet (1968) 1.04
Staphylococcus aureus among insulin-injecting diabetic patients. An increased carrier rate. JAMA (1975) 1.04
Effects of allopurinol, propranolol and methylprednisolone on infarct size in experimental myocardial infarction. Am J Cardiol (1976) 1.04
Cardiac, pulmonary and neuromuscular effects of clenbuterol and terbutaline compared with placebo. Br J Clin Pharmacol (1981) 1.04
Effects of ouabain on splanchnic hemodynamics in the rhesus monkey. Am Heart J (1971) 1.03
Reticuloendothelial system phagocytic function in naturally acquired human malaria. J Lab Clin Med (1970) 1.03
Hypothalamic-pituitary-adrenocortical responses to psychological stress and caffeine in men at high and low risk for hypertension. Psychosom Med (1998) 1.03
Outcomes of trauma patients with no vital signs on hospital admission. J Trauma (1983) 1.03
Effects of caffeine on vascular resistance, cardiac output and myocardial contractility in young men. Am J Cardiol (1985) 1.02
Teichoic acids in pathogenic Staphylococcus aureus. J Clin Microbiol (1977) 1.02
Total pancreatectomy for ductal carcinoma of the head of the pancreas: current status. Am J Surg (1976) 1.02
Effects of endotoxin on myocardial hemodynamics, performance, and metabolism. Am J Physiol (1971) 1.01
Minor salivary gland involvement in sarcoidosis. Report of 3 cases with positive lip biopsies. Oral Surg Oral Med Oral Pathol (1972) 1.01
Technical aspects of the Staphylococcus aureus teichoic acid antibody assay: gel diffusion and counterimmunoelecrophoretic assays, antigen preparation, antigen selection, concentration effects, and cross-reactions with other organisms. J Clin Microbiol (1981) 1.01
Responses of the baboon to live Escherichia coli organisms and endotoxin. Surg Gynecol Obstet (1977) 1.01
Presenting manifestations, cigarette smoking, and detection bias in age at diagnosis of lung cancer. Ann Epidemiol (2001) 1.01